Caribou Biosciences CRBU Cash Flow Statement (2020-2026)

NASDAQ CRBU
$0.56 +0.02 (+2.87%)
At close: Oct 22, 2026 · 4:00 PM EDT
Reported Financials

Caribou Biosciences Quarterly Cash Flow Statement

Periods 26 quarters
Latest Jun 2026

Caribou Biosciences reported cash from operations of -$22.80M and free cash flow of -$22.80M for the quarter ended Jun 2026, up 19.3% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-20.97M-18.48M-19.09M-26.70M-26.65M-26.99M-28.04M-29.52M-10.00M-34.51M-41.23M-37.70M-34.68M-35.49M-39.99M-54.10M-27.55M-26.49M-25.09M-24.28M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.26M0.27M0.31M0.36M0.45M0.51M0.59M0.62M1.58M0.74M0.71M0.86M1.18M1.18M1.17M1.17M0.63M0.68M0.65M0.63M
Share-based CompensationStock Comp.
0.94M1.58M3.02M2.92M2.67M3.10M3.13M3.59M3.48M3.56M3.99M4.74M4.07M3.91M3.88M3.13M2.93M2.74M2.36M2.48M
Gains from Sales and DivestituresGains Divest
0.00M0.03M0.00M0.01M
Gains from Investment SecuritiesGains Investment
-0.09M-0.02M0.03M-0.06M-0.02M0.02M0.00M-0.01M-0.10M-0.01M0.01M-0.01M0.02M0.01M-0.12M
Asset Writedowns and ImpairmentWritedown
9.20M12.15M0.05M
Other non-cash itemsOther Non-Cash
2.40M-2.16M-1.10M-1.05M1.61M-1.29M0.26M-0.28M0.14M2.18M0.22M-1.80M0.16M0.26M0.16M-0.45M0.42M0.32M0.32M
Change in Working Capital
Change in ReceivablesChange Receivables
0.58M0.58M-0.78M0.15M-0.13M-0.20M1.33M-0.77M0.37M-0.99M0.77M-0.70M-0.03M0.08M-0.18M-0.02M0.17M-0.17M0.16M-0.02M
Change in Account PayablesChange Payables
-0.18M0.29M-1.92M-1.64M0.99M-0.15M1.50M0.54M-0.95M0.73M2.72M-2.37M-0.48M-0.23M1.40M-0.63M0.56M1.92M-2.22M-0.42M
Change in Accured ExpensesChange Accured Exp.
3.85M-0.57M-2.83M3.95M-0.21M1.04M-4.14M3.71M3.28M2.90M-2.20M4.97M1.58M-2.21M-3.10M0.69M-1.11M-2.82M-2.65M-0.74M
Change in Other Operating AssetsOther Assets Change
-0.28M1.21M0.48M-1.59M0.71M-0.57M-3.03M-0.94M2.68M-1.19M-0.05M-0.75M3.15M1.29M-1.28M-1.70M-0.33M-3.79M-1.36M-0.40M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.96M-0.59M-0.67M-2.00M-0.90M-1.79M-1.42M6.14M-21.35M-0.78M-0.64M-1.19M-0.81M-0.49M-1.26M-1.22M-1.02M-1.20M-1.29M-1.14M
Other Working Capital ChangesOther WC Changes
-0.68M-1.80M-1.14M-0.42M-1.62M-1.21M1.61M7.08M-24.03M0.41M-0.60M-0.44M-3.96M-1.79M0.02M0.48M-0.69M2.59M0.07M-0.74M
Cash from OperationsCash from Ops.
-14.97M-21.39M-21.67M-21.87M-22.38M-25.04M-27.94M-15.19M-28.79M-21.38M-37.20M-32.87M-32.66M-35.47M-36.73M-28.26M-25.22M-20.80M-27.00M-22.80M
Investing Activities
Capital ExpendituresCapex
0.93M0.69M0.72M2.62M1.35M1.76M2.03M2.55M4.75M2.28M1.45M2.24M0.67M0.52M1.04M0.42M0.12M-0.22M0.07M0.00M
Change in Property, Plant and EquipmentChange in PP&E
-0.93M-0.69M-0.72M-2.62M-1.35M-1.76M-2.03M-2.55M-4.75M-2.28M-1.45M-2.24M-0.67M-0.52M-1.04M-0.42M-0.12M0.22M-0.07M0.00M
Change in IntangiblesChange Intangibless
1.00M0.30M1.50M0.13M
Purchase of InvestmentsInvestments Purchased
173.28M110.68M71.06M70.81M86.51M75.93M58.74M175.89M84.19M71.18M84.24M93.47M55.50M15.53M32.22M57.45M44.03M22.09M20.50M
Sale and Maturity of InvestmentsInvestments Sold
78.60M119.42M128.24M179.48M98.67M72.36M112.17M55.00M97.09M107.80M120.66M71.94M65.96M56.67M68.41M61.79M46.14M39.45M
Cash from Investing ActivitiesCash from Investing
-1.93M-173.96M-72.11M-13.97M-8.34M1.17M20.70M11.06M-68.48M-31.47M22.96M21.20M26.52M15.93M49.38M24.04M10.85M17.97M23.99M18.94M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Long-Term Debt RepaymentsLT Debt Repayment
Non-Current Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
Change in Capital Stock
Common Stock IssuedStock Issued
321.98M0.46M0.99M0.36M0.65M0.13M1.64M17.50M0.59M0.07M12.49M0.13M0.24M3.86M0.47M0.01M0.28M4.07M2.70M17.94M
Net Shares Issued and RepurchasedNet Shares Issued
321.98M0.46M0.99M0.36M0.65M0.13M1.64M17.50M0.59M0.07M12.49M0.13M0.24M3.86M0.47M0.01M0.28M4.07M2.70M17.94M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
321.98M0.46M0.99M0.36M0.65M0.13M1.64M17.50M0.59M0.07M12.49M0.13M0.24M3.86M0.47M0.01M0.28M4.07M2.70M17.94M
Cash from Financing ActivitiesCash from Financing
322.68M0.46M0.99M0.36M0.65M0.13M1.64M17.57M135.13M-0.04M12.49M0.13M0.24M3.86M0.47M0.01M0.28M4.07M2.70M17.94M
Additional items
Change in Cash
305.79M-194.89M-92.79M-35.48M-30.06M-23.75M-5.59M13.45M37.86M-52.90M-1.76M-11.53M-5.90M-15.68M13.12M-4.22M-14.06M1.22M-0.30M14.09M
Ending Cash Balance
435.36M240.47M147.68M112.19M82.13M58.38M52.79M66.24M104.10M51.21M49.45M37.91M32.02M16.34M29.46M25.25M11.19M12.41M12.10M26.19M
Free Cash FlowFCF
-15.90M-22.07M-22.40M-24.49M-23.73M-26.80M-29.97M-17.74M-33.54M-23.66M-38.65M-35.11M-33.33M-35.99M-37.77M-28.68M-25.33M-20.58M-27.07M-22.80M
Net Cash FlowNCF
305.79M-194.89M-92.79M-35.48M-30.06M-23.75M-5.59M13.45M37.86M-52.90M-1.76M-11.53M-5.90M-15.68M13.12M-4.22M-14.09M1.24M-0.32M14.08M
Interest Paid
Income Taxes PaidTaxes Paid

Caribou Biosciences Cash Flow Statement API

Pull Caribou Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CRBU&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY